
Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
Year | Award Type | Project # |
RFA #![]() |
PI/Project Leader | Institution | Title | Status |
---|---|---|---|---|---|---|---|
2000 | R21 | CA084691 | PAR-98-067 | MELDRUM, DEIRDRE R. | UNIVERSITY OF WASHINGTON | AUTOMATED MINIMAL RESIDUAL DISEASE QUANTIFICATION | Complete |
1999 | R33 | CA083238 | PAR-98-067 | RAMSEY, JOHN MICHAEL | LOCKHEED MARTIN ENERGY RESEARCH CORP | DEVICES FOR HIGH THROUGHPUT CELLULAR PROTEIN ANALYSIS | Complete |
2000 | R21 | CA084712 | PAR-98-067 | HADDAD, BASSEM R | GEORGETOWN UNIVERSITY | CYTOGENETIC SCREENING OF MAMMARY EPITHELIAL CELLS | Complete |
2000 | R21 | CA084740 | PAR-98-067 | ENGELWARD, BEVIN P. | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | FLUORESCENCE DETECTION OF GENETIC INSTABILITY IN MICE | Complete |
1999 | R33 | CA081665 | PAR-98-067 | YATES, JOHN ROBERT | UNIVERSITY OF WASHINGTON | DIRECT MS ANALYSIS OF COMPLEX PROTEIN MIXTURES | Complete |
1999 | R43 | CA081860 | PAR-98-066 | CHANG, HWAI W | STRATAGENE | GENETIC SELECTION FOR PROTEASES AND THEIR SUBSTRATES | Complete |
1999 | R43 | CA081870 | PAR-98-066 | MILLER, JEFFREY E. | IVS TECHNOLOGIES, LLC | NEW METHOD FOR THE SYNTHESIS OF CDNA FROM CANCER CELLS | Complete |
2000 | R41 | CA083369 | PAR-98-066 | SWENBERG, JAMES A | ENO RIVER LABS, LLC | ULTRASENSITIVE METHODS FOR HUMAN DNA ADDUCT QUANTITATION | Complete |
1999 | R43 | CA081890 | PAR-98-066 | NERI, BRUCE P | THIRD WAVE TECHNOLOGIES, INC. | SPECIFIC AND SENSITIVE MUTATION AND SNP DETECTION | Complete |
2000 | R41 | CA084688 | PAR-98-066 | SKIPPER, PAUL L | NEWTON SCIENTIFIC, INC. | TRITIUM AMS ANALYSIS OF CANCER BIOMARKERS | Complete |
1999 | R43 | CA081891 | PAR-98-066 | WEAVER, DANIEL C | GENOMICA CORPORATION | ANALYZING GENE EXPRESSION FOR CANCER GENE DISCOVERY | Complete |
2000 | R41 | CA084693 | PAR-98-066 | LIFSHITZ, NADIA | BIOPHOTONICS CORPORATION | MONOLITHIC MULTI-CAPILLARY ARRAYS TO SEQUENCE DNA | Complete |
1999 | R43 | CA081903 | PAR-98-066 | TS'O, PAUL O. P. | CCC DIAGNOSTICS, LLC | ISOLATION AND PROFILING OF CIRCULATING PC CELLS IN BLOOD | Complete |
1999 | R43 | CA081949 | PAR-98-066 | OLINER, JONATHAN D | AFFYMETRIX, INC. | REVERSE-ENGINEERING SIGNAL TRANSDUCTION NETWORKS | Complete |
2000 | R43 | CA084678 | PAR-98-066 | BAMDAD, CYNTHIA C. | MINERVA BIOTECHNOLOGIES CORPORATION | RAPID ELECTRONIC DETECTION OF CELL SURFACE PROTEINS | Complete |
1999 | R43 | CA081951 | PAR-98-066 | XANTHOPOULOS, KLEANTHIS G | AURORA BIOSCIENCES CORPORATION | ID OF NOVEL BREAST CANCER AGENTS BY FUNCTIONAL GENOMICS | Complete |
2001 | R43 | CA084679 | PAR-98-066 | PERLIN, MARK W | CYBERGENETICS CORPORATION | AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY | Complete |
2000 | R43 | CA084679 | PAR-98-066 | PERLIN, MARK W | CYBERGENETICS CORPORATION | AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY | Complete |
1999 | R43 | CA081952 | PAR-98-066 | CHEE, MARK S. | ILLUMINA, INC. | GENE EXPRESSION ANALYSIS ON RANDOMLY ORDERED DNA ARRAYS | Complete |
2000 | R43 | CA084686 | PAR-98-066 | BOGEN, STEVEN A | CYTOLOGIX CORPORATION | INSTRUMENTATION FOR IN SITU ANALYSIS TUMORS | Complete |
1999 | R43 | CA081958 | PAR-98-066 | HAGEN, FREDERICK S | ICOGENEX CORPORATION | AFFINITY AND TRANSCRIPTASE TECHNOLOGIES | Complete |
1999 | R43 | CA081962 | PAR-98-066 | GERDES, JOHN CHARLES | XTRANA, INC. | QUANTITATION AND ARCHIVING OF GENE EXPRESSION | Complete |
1999 | R43 | CA081965 | PAR-98-066 | BITTER, GRANT A. | BITTECH, INC. | DNA MISMATCH REPAIR FUNCTIONAL GENETIC TESTS | Complete |
1999 | R43 | CA083382 | PAR-98-066 | MONFORTE, JOSEPH A | GENETRACE SYSTEMS, INC. | EXPRESSION MONITORING OF MULTIPLEXED CANCER GENE SETS | Complete |
1999 | R43 | CA083384 | PAR-98-066 | RICHTERICH, PETER | CODONCODE CORPORATION | SOFTWARE FOR SEQUENCING BASED MUTATION DETECTION | Complete |
1999 | R43 | CA083385 | PAR-98-066 | GOLDRICK, MARIANNA M | AMBION, INC. | DETECTION AND QUANTITATION OF FUSION MRNAS IN LEUKEMIA | Complete |
1999 | R43 | CA083388 | PAR-98-066 | CRONIN, MAUREEN T. | PROTOGENE LABORATORIES, INC. | DEVELOPMENT OF DNA MICROARRAY FABRICATION METHOD | Complete |
1999 | R43 | CA083390 | PAR-98-066 | WIKTOR, PETER J. | ENGINEERING ARTS | PIEZO ELECTRIC PIPETTING TECHNOLOGY FOR DNA ANALYSIS | Complete |
1999 | R43 | CA083396 | PAR-98-066 | GITE, SADANAND | AMBERGEN, INC | NOVEL TECHNOLOGY FOR THE ANALYSIS OF GENE EXPRESSION | Complete |
1999 | R43 | CA083398 | PAR-98-066 | CHEE, MARK S. | ILLUMINA, INC. | PARALLEL ARRAY PROCESSOR | Complete |
2000 | R44 | CA081954 | PAR-98-066 | LIFSHITZ, NADIA | BIOPHOTONICS CORPORATION | HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING | Complete |
1999 | R43 | CA083402 | PAR-98-066 | BEACH, DAVID H. | GENETICA, INC. | TECHNOLOGIES FOR GENETIC MANIPULATION OF TUMOR CELLS | Complete |
2000 | R44 | CA082038 | PAR-98-066 | ANDERSON, N LEIGH | LARGE SCALE BIOLOGY CORPORATION | PROTEOMIC TECHNOLOGIES FOR CANCER RESEARCH | Complete |
1999 | R43 | CA083477 | PAR-98-066 | WINZER-SERHAN, URSULA H | AMBION, INC. | DEVELOPMENT OF RNA FRIENDLY, HISTOLOGICAL FIXATIVES | Complete |
2000 | R21 | CA083391 | PAR-98-066 | HAMPDEN-SMITH, MARK J | SUPERIOR MICROPOWDERS, LLC | UNIQUE, SMALL PARTICLE PHOSPHOR POWDERS FOR IMUNOASSAYS | Complete |
1999 | R44 | CA081954 | PAR-98-066 | LIFSHITZ, NADIA | BIOPHOTONICS CORPORATION | HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING | Complete |
1999 | R44 | CA082038 | PAR-98-066 | ANDERSON, N LEIGH | LARGE SCALE BIOLOGY CORPORATION | PROTEOMIC TECHNOLOGIES FOR CANCER RESEARCH | Complete |
1999 | R41 | CA081825 | PAR-98-066 | MACH, ROBERT H | ANASAZI BIOMEDICAL RESEARCH, INC. | SIGMA 1 RECEPTOR PROBES FOR IMAGING TUMOR PROLIFERATION | Complete |
1999 | R43 | CA081835 | PAR-98-066 | MOSTERT, MICHAEL J | ECHELON BIOSCIENCES, INC. | PHOSPHOINOSITIDE 3-KINASE ASSAYS IN CANCER DIAGNOSIS | Complete |
2020 | R44 | CA247353 | PAR-18-303 | FRIEDA, KIRSTEN | SPATIAL GENOMICS, INC. | Spatial and single cell analysis of tumor microenvironment by seqFISH+ | Active |
2020 | R43 | CA250805 | PAR-18-303 | WANG, SHA | VIVID TECHNOLOGIES | New specific and rapid assay for in situ apoptosis labeling for cancer studies | Active |
2021 | R44 | CA261523 | PAR-18-303 | HUNG, PAUL JU-SUNG | COMBINATI, INC. | Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring | Active |
2020 | R44 | CA243990 | PAR-18-303 | GURARD-LEVIN, ZACHARY | SAMDI TECH, INC. | Development Of The First Label-free And High-throughput, Cell-based Assay That Reports On Specific Enzyme Activities | Active |
2020 | R44 | CA236097 | PAR-18-303 | LIM, MARK | AMBERGEN, INC | Highly Multiplexed Nanoscale Mass Spectrometric Imaging Of Cancer Tissues | Active |
2020 | R43 | CA250885 | PAR-18-303 | REDER, NICHOLAS | LIGHTSPEED MICROSCOPY, INC. | Open-top Light-sheet Microscopy For Non-destructive 3d Pathology Of Prostate Biopsies | Active |
2018 | R43 | CA236097 | PAR-18-303 | LIM, MARK | AMBERGEN, INC | Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues | Active |
2018 | R43 | CA236101 | PAR-18-303 | LEE, LY JAMES | NANOMATERIAL INNOVATION, LTD | Molecular Beacons in Lipoplex Nanoparticles for Extracellular Vesicles Based Cancer Diagnosis | Complete |
2018 | R43 | CA236142 | PAR-18-303 | SCHOETTLE, LOUIS | GEMNEO BIOSCIENCE, INC. | Origami Nanoprobes for Large-Scale Single-Cell Analysis of Lymphocytes | Complete |
2020 | R43 | CA236167 | PAR-18-303 | WARREN, CHRISTOPHER L | PROTEOVISTA, LLC | Development Of The High Throughput Apt-snap Platform For Rapid Identification Ofnuclease-resistant Rna Aptamers Against P53 Missense Mutations | Active |
2019 | R43 | CA236103 | PAR-18-303 | KHODAVERDIAN, VARANDT Y. | NUPROBE USA, INC. | Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing | Complete |